1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (1812)
  2. Meeting Abstract (932)
  3. Book Section (169)
  4. Review (156)
  5. Editorial (44)
  6. Conference Paper (40)
  7. Guidelines (31)
  8. Miscellaneous (18)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)

More Groups

People
  1. Steven Larson (957)
  2. Heiko Schoder (543)
  3. Neeta Pandit-Taskar (342)
  4. John Humm (281)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (205)

More People

Years
  1. 2025 (40)
  2. 2024 (129)
  3. 2023 (176)
  4. 2022 (175)
  5. 2021 (197)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (569)
  2. Journal of Clinical Oncology (248)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (97)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (569)
  2. Springer (430)
  3. Elsevier Inc. (303)
  4. American Society of Clinical Oncology (259)
  5. Lippincott Williams & Wilkins (154)
  6. American Association for Cancer Research (150)

More Publishers

Results (3230)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hormonal regulation of background parenchymal enhancement at contrast-enhanced mammography
    Journal Article

    Nissan, N.; Sevilimedu, V.; Gluskin, J.; Arita, Y.; Keating, D. M.; D'Alessio, D.; Fruchtman-Brot, H.; Ochoa-Albiztegui, R. E.; Sung, J. S.; Jochelson, M. S.
    Radiology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Carrier-free nanoparticles for cancer theranostics with dual-mode magnetic resonance imaging/fluorescence imaging and combination photothermal and chemodynamic therapy
    Journal Article

    Ding, Y.; Deng, C.; Yang, Y.; Zhang, J.; Liu, W.; Aras, O.; An, F.; Liu, J.; Chai, Y.
    International Journal of Pharmaceutics (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Asymmetric background parenchymal enhancement on contrast-enhanced mammography: Associated factors, diagnostic workup, and clinical outcome
    Journal Article

    Nissan, N.; Gluskin, J.; Ochoa-Albiztegui, R. E.; Sung, J. S.; Jochelson, M. S.
    European Radiology (2025)

    Fulltext@MSK | Save
  • Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies
    Journal Article

    Skubal, M.; Mc Larney, B.; Phung, N. B.; Desmaras, J. C.; Dozic, A. V.; Volpe, A.; Ogirala, A.; Longo Machado, C.; Djibankov, J.; Ponomarev, V.; more...
    Theranostics (2025)

    Fulltext@MSK | Save
  • Harnessing the tumor microenvironment: Targeted cancer therapies through modulation of epithelial-mesenchymal transition
    Review

    Glaviano, A.; Lau, H. S. H.; Carter, L. M.; Lee, E. H. C.; Lam, H. Y.; Okina, E.; Tan, D. J. J.; Tan, W.; Ang, H. L.; Carbone, D.; more...
    Journal of Hematology & Oncology (2025)

    Fulltext@MSK | Save
  • PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma
    Journal Article

    White, C.; Jayaprakasam, V. S.; Tenet, M.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Maron, S. B.; Schöder, H.; Larson, S. M.; Gönen, M.; more...
    European Journal of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Non-enhancing asymmetries on screening contrast-enhanced mammography: Is further diagnostic workup required?
    Journal Article

    Nissan, N.; Reiner, J. S.; Mango, V. L.; Fruchtman-Brot, H.; Albiztegui, R. E. O.; Arita, Y.; Gluskin, J.; Amir, T.; Feigin, K.; Jochelson, M. S.; more...
    European Journal of Radiology (2025)

    Fulltext@MSK | Save